The global Smart Pills Market ,valued at US$0.61 billion in 2023, is forecasted to grow at a robust CAGR of 11.2%, reaching US$0.69 billion in 2024 and an impressive US$1.30 billion by 2030. The key ...

All of the board of directors nominees listed in the Circular were re-elected as directors of Microbix ... and reagents or media to support molecular diagnostic testing (e.g., its DxTM for ...

In connection with AcouSort's announcement of its plan to carry out a rights issue, several shareholders have contacted the company with questions regarding both the issue itself and how the managemen ...

We’re excited to announce the judges of the 2025 Innovation by Design Awards. Innovation by Design honors the best projects ...

The global Drug Discovery Services Market , valued at US$14.89 billion in 2024, is forecasted to grow at a robust CAGR of 10.7%, reaching US$16.36 billion in 2025 and an impressive US$27.23 billion by ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

(Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing ... Appointed Fran Schulz and Feng Hsiung to the Board of Directors ("Board"): In December 2024, Fran ...

In the latest move to cement its “immunology powerhouse” status, Sanofi is handing over $600 million upfront for Dren Bio’s clinical-stage bispecific antibody, with more than $1 billion in ...

While they aren’t involved in day-to-day operations, non-executive directors hold the highest decision-making authority within a company. Collectively, the board is responsible for a company’s ...

Consequently, both will cease to be Independent Non-executive Directors of the Company at the conclusion of the AGM. Upon their retirement, they will also step down from their roles as chairmen and ...

Karim Budhwani, founder and CEO-scientist of Cerflux who was appointed as chair of BIO Alabama’s Board of Directors, said while these cuts don’t directly affect the organization’s financial ...